QuantiFERON-TB Gold PLUS versus QuantiFERON-TB Gold In-Tube test for diagnosing tuberculosis infection

Background/Aims QuantiFERON-TB Gold PLUS (QFT-PLUS) was developed as a new version of the interferon-γ (IFN-γ) release assay that contains an extra antigen tube to elicit a CD8+ T-cell response in addition to a CD4+ T-cell response. This study aimed to evaluate the performances of QFT-PLUS versus Qu...

Full description

Bibliographic Details
Main Authors: Soo Han Kim, Kyung-Wook Jo, Tae Sun Shim
Format: Article
Language:English
Published: The Korean Association of Internal Medicine 2020-03-01
Series:The Korean Journal of Internal Medicine
Subjects:
Online Access:http://www.kjim.org/upload/pdf/kjim-2019-002.pdf
_version_ 1819112472535105536
author Soo Han Kim
Kyung-Wook Jo
Tae Sun Shim
author_facet Soo Han Kim
Kyung-Wook Jo
Tae Sun Shim
author_sort Soo Han Kim
collection DOAJ
description Background/Aims QuantiFERON-TB Gold PLUS (QFT-PLUS) was developed as a new version of the interferon-γ (IFN-γ) release assay that contains an extra antigen tube to elicit a CD8+ T-cell response in addition to a CD4+ T-cell response. This study aimed to evaluate the performances of QFT-PLUS versus QuantiFERON-TB Gold In-Tube (QFT-GIT) for detecting tuberculosis (TB) infection. Methods Between October, 2016 and May, 2018, 137 participants were prospectively recruited and subjected to QFT-GIT and QFT-PLUS testing. The concordance between tests and performance based on different immune states and/or TB infection risk were evaluated. Results The 137 participants were classified as follows: active TB (n = 14), TB contact (n = 14), screening before biologic therapy (n = 85) and other disease (n = 24). The positive results for either test were 100% (n = 14/14), 42.9% (n = 6/14), 15.3% (n = 13/85), and 62.5% (n = 15/24) in each four groups, respectively. The QFT-GIT and QFT-PLUS test results showed good concordance with 91.2% agreement and a Cohen’s κ of 0.807. The good concordance between two tests was also observed in 64 immunocompromised subjects (agreement of 90.6% and a Cohen’s κ of 0.711). The intra-class correlation coefficient for each antigen tube of the QFT-PLUS showed a good correlation with the IFN-γ release of the QFT-GIT (TB1 = 0.912, p < 0.001; TB2 = 0.918, p < 0.001). Conclusions QFT-PLUS showed highly comparable results to those of QFT-GIT for diagnosing TB infection in South Korea as well as in immunocompromised subjects.
first_indexed 2024-12-22T04:14:03Z
format Article
id doaj.art-7d5a47ced1994066a13e4e0e24846df2
institution Directory Open Access Journal
issn 1226-3303
2005-6648
language English
last_indexed 2024-12-22T04:14:03Z
publishDate 2020-03-01
publisher The Korean Association of Internal Medicine
record_format Article
series The Korean Journal of Internal Medicine
spelling doaj.art-7d5a47ced1994066a13e4e0e24846df22022-12-21T18:39:28ZengThe Korean Association of Internal MedicineThe Korean Journal of Internal Medicine1226-33032005-66482020-03-0135238339110.3904/kjim.2019.002170281QuantiFERON-TB Gold PLUS versus QuantiFERON-TB Gold In-Tube test for diagnosing tuberculosis infectionSoo Han Kim0Kyung-Wook Jo1Tae Sun Shim2 Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaBackground/Aims QuantiFERON-TB Gold PLUS (QFT-PLUS) was developed as a new version of the interferon-γ (IFN-γ) release assay that contains an extra antigen tube to elicit a CD8+ T-cell response in addition to a CD4+ T-cell response. This study aimed to evaluate the performances of QFT-PLUS versus QuantiFERON-TB Gold In-Tube (QFT-GIT) for detecting tuberculosis (TB) infection. Methods Between October, 2016 and May, 2018, 137 participants were prospectively recruited and subjected to QFT-GIT and QFT-PLUS testing. The concordance between tests and performance based on different immune states and/or TB infection risk were evaluated. Results The 137 participants were classified as follows: active TB (n = 14), TB contact (n = 14), screening before biologic therapy (n = 85) and other disease (n = 24). The positive results for either test were 100% (n = 14/14), 42.9% (n = 6/14), 15.3% (n = 13/85), and 62.5% (n = 15/24) in each four groups, respectively. The QFT-GIT and QFT-PLUS test results showed good concordance with 91.2% agreement and a Cohen’s κ of 0.807. The good concordance between two tests was also observed in 64 immunocompromised subjects (agreement of 90.6% and a Cohen’s κ of 0.711). The intra-class correlation coefficient for each antigen tube of the QFT-PLUS showed a good correlation with the IFN-γ release of the QFT-GIT (TB1 = 0.912, p < 0.001; TB2 = 0.918, p < 0.001). Conclusions QFT-PLUS showed highly comparable results to those of QFT-GIT for diagnosing TB infection in South Korea as well as in immunocompromised subjects.http://www.kjim.org/upload/pdf/kjim-2019-002.pdflatent tuberculosisinterferon-gamma release testscd8-positive t-lymphocyte
spellingShingle Soo Han Kim
Kyung-Wook Jo
Tae Sun Shim
QuantiFERON-TB Gold PLUS versus QuantiFERON-TB Gold In-Tube test for diagnosing tuberculosis infection
The Korean Journal of Internal Medicine
latent tuberculosis
interferon-gamma release tests
cd8-positive t-lymphocyte
title QuantiFERON-TB Gold PLUS versus QuantiFERON-TB Gold In-Tube test for diagnosing tuberculosis infection
title_full QuantiFERON-TB Gold PLUS versus QuantiFERON-TB Gold In-Tube test for diagnosing tuberculosis infection
title_fullStr QuantiFERON-TB Gold PLUS versus QuantiFERON-TB Gold In-Tube test for diagnosing tuberculosis infection
title_full_unstemmed QuantiFERON-TB Gold PLUS versus QuantiFERON-TB Gold In-Tube test for diagnosing tuberculosis infection
title_short QuantiFERON-TB Gold PLUS versus QuantiFERON-TB Gold In-Tube test for diagnosing tuberculosis infection
title_sort quantiferon tb gold plus versus quantiferon tb gold in tube test for diagnosing tuberculosis infection
topic latent tuberculosis
interferon-gamma release tests
cd8-positive t-lymphocyte
url http://www.kjim.org/upload/pdf/kjim-2019-002.pdf
work_keys_str_mv AT soohankim quantiferontbgoldplusversusquantiferontbgoldintubetestfordiagnosingtuberculosisinfection
AT kyungwookjo quantiferontbgoldplusversusquantiferontbgoldintubetestfordiagnosingtuberculosisinfection
AT taesunshim quantiferontbgoldplusversusquantiferontbgoldintubetestfordiagnosingtuberculosisinfection